The Supreme Court has granted a temporary extension of access to the abortion pill mifepristone until Friday while they consider a legal challenge to the medication's FDA approval. The lower court ruling had increased the gestational age limit for using the drug and reduced the number of required in-person visits. The Biden administration and drug maker Danco Laboratories have requested the Supreme Court to halt the appeals court ruling. The temporary extension of access to mifepristone will remain in place until Friday at 11:59 p.m.
